Ultragenyx Pharmaceutical
RARE
#3817
Rank
โ‚น291.70 B
Marketcap
โ‚น3,024
Share price
2.01%
Change (1 day)
-18.44%
Change (1 year)

Market capitalization of Ultragenyx Pharmaceutical (RARE)

Market cap: โ‚น291.70 Billion

As of December 2025 Ultragenyx Pharmaceutical has a market cap of โ‚น291.70 Billion. This makes Ultragenyx Pharmaceutical the world's 3817th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Ultragenyx Pharmaceutical from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น291.70 B-15.19%
2024โ‚น343.96 B5.22%
2023โ‚น326.89 B21.63%
2022โ‚น268.77 B-37%
2021โ‚น426.62 B-36.3%
2020โ‚น669.75 B280.2%
2019โ‚น176.15 B13.92%
2018โ‚น154.62 B22.6%
2017โ‚น126.12 B-35.4%
2016โ‚น195.22 B-32.65%
2015โ‚น289.86 B226.38%
2014โ‚น88.81 B

End of Day market cap according to different sources

On Dec 19th, 2025 the market cap of Ultragenyx Pharmaceutical was reported to be:

โ‚น291.70 Billion
by Nasdaq info icon info icon
โ‚น291.70 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
BioMarin Pharmaceutical
BMRN
โ‚น1.060 T 263.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚น394.86 B 35.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚น84.08 B-71.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
โ‚น38.37 B-86.84%๐Ÿ‡บ๐Ÿ‡ธ USA